Theranostics 2022; 12(10):4604-4605. doi:10.7150/thno.74233 This issue

Erratum

H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts: Erratum

Ying Zhang1,2#, Zhaoyong Liu3#, Xia Yang1,2, Weiqing Lu3, Yelong Chen3, Youbin Lin3, Jin Wang1,4, Suxia Lin1,2✉, Jing-Ping Yun1,2✉

1. Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
2. Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
3. Department of Orthopedics, First Affiliated Hospital of Shantou University Medical College, No.57 Changping Road, Shantou, Guangdong 515041, China.
4. Department of Orthopedics, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
#These authors contributed equally to this work.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Zhang Y, Liu Z, Yang X, Lu W, Chen Y, Lin Y, Wang J, Lin S, Yun JP. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts: Erratum. Theranostics 2022; 12(10):4604-4605. doi:10.7150/thno.74233. Available from https://www.thno.org/v12p4604.htm

File import instruction

Corrected-article in Theranostics, Volume 11, 1473